# A Study to Evaluate the Efficacy, Safety, and Tolerability of NDI-034858 in Participants With Active Psoriatic Arthritis

> **NCT05153148** · PHASE2 · COMPLETED · sponsor: **Takeda** · enrollment: 305 (actual)

## Conditions studied

- Psoriatic Arthritis

## Interventions

- **DRUG:** NDI-034858
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05153148
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-06
- **Primary completion:** 2023-05-04
- **Final completion:** 2023-06-02
- **Target enrollment:** 305 (ACTUAL)
- **Last updated:** 2024-05-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05153148

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05153148, "A Study to Evaluate the Efficacy, Safety, and Tolerability of NDI-034858 in Participants With Active Psoriatic Arthritis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05153148. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*